301 related articles for article (PubMed ID: 27825121)
1. Prognostic and clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors: evidence from a meta-analysis.
Liu FT; Pan H; Xia GF; Qiu C; Zhu ZM
Oncotarget; 2016 Dec; 7(50):83177-83186. PubMed ID: 27825121
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of long non-coding RNA UCA1 in human solid tumors.
Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C
Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis.
Yang C; Li Z; Li Y; Xu R; Wang Y; Tian Y; Chen W
Oncotarget; 2017 Jan; 8(2):2672-2680. PubMed ID: 27926523
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of long non-coding RNA H19 in various cancers: A meta-analysis based on 15 studies with 1584 patients and the Cancer Genome Atlas data.
Yu H; Li S; Wu SX; Huang S; Li S; Ye L
Medicine (Baltimore); 2020 Jan; 99(2):e18533. PubMed ID: 31914026
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis.
Mehrad-Majd H; Akhtari J; Haerian MS; Ravanshad Y
J Cell Physiol; 2019 Apr; 234(4):4206-4216. PubMed ID: 30191982
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
[TBL] [Abstract][Full Text] [Related]
9. Long non coding RNA XIST as a prognostic cancer marker - A meta-analysis.
Zhou Q; Hu W; Zhu W; Zhang F; Lin-Lin L; Liu C; Songyang YY; Sun CC; Li D
Clin Chim Acta; 2018 Jul; 482():1-7. PubMed ID: 29577911
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA H19 can predict a poor prognosis and lymph node metastasis: a meta-analysis in human cancer.
Chen T; Yang P; He ZY
Minerva Med; 2016 Aug; 107(4):251-8. PubMed ID: 27348443
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of lncRNA DANCR expression in human cancers: a systematic review and meta-analysis.
Liu W; Wang QP; Guo J
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 30910838
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.
Wang M; Dong X; Feng Y; Sun H; Shan N; Lu T
Oncotarget; 2017 May; 8(20):33713-33724. PubMed ID: 28410241
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
[No Abstract] [Full Text] [Related]
15. Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association with Pathological Features.
Lin Y; Xu L; Wei W; Zhang X; Ying R
Biomed Res Int; 2016; 2016():4863609. PubMed ID: 27738631
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostic value of lncRNA BANCR in tumor patients: A systematic review and meta-analysis.
Zhang G; Cai J
J BUON; 2019; 24(6):2553-2559. PubMed ID: 31983132
[TBL] [Abstract][Full Text] [Related]
17. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
Tian S; Liu J; Kong S; Peng L
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-10b expression predicts long-term survival in patients with solid tumor.
Zhang Y; Wang LJ; Yang HQ; Wang R; Wu HJ
J Cell Physiol; 2019 Feb; 234(2):1248-1256. PubMed ID: 30191959
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PANDAR as a prognostic marker in Chinese cancer.
Ma PJ; Guan QK; Xu DW; Zhao J; Qin N; Jin BZ
Clin Chim Acta; 2017 Dec; 475():172-177. PubMed ID: 29066211
[TBL] [Abstract][Full Text] [Related]
20. High expression of long noncoding RNA LUCAT1 correlates with a poor clinical outcome in solid tumors: A systematic review and meta-analysis.
Lv P; Ye T; Yang X; Liu H; Ye Z
Pathol Res Pract; 2020 Sep; 216(9):153047. PubMed ID: 32825932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
